Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Recombinant Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Recombinant Fusion Proteins < Recombinant Proteins < Recovery of Function  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000678 (2018) Yusuke Takayama [Japon] ; Tetsuya Kubota [Japon] ; Yoshitaka Ogino [Japon] ; Hiroshi Ohnishi [Japon] ; Kazuto Togitani [Japon] ; Akihito Yokoyama [Japon]TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
000766 (2018) Chuanfei Yu [République populaire de Chine] ; Junxia Cao [République populaire de Chine] ; Lan Wang [République populaire de Chine] ; Yalan Yang [République populaire de Chine] ; Yongbo Ni [République populaire de Chine] ; Junzhi Wang [République populaire de Chine]Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay.
001207 (2015) E M Dijkgraaf [Pays-Bas] ; S J A M. Santegoets [Pays-Bas] ; A K L. Reyners ; R. Goedemans [Pays-Bas] ; M C A. Wouters [Pays-Bas] ; G G Kenter [Pays-Bas] ; A R Van Erkel ; M I E. Van Poelgeest [Pays-Bas] ; H W Nijman ; J J M. Van Der Hoeven [Pays-Bas] ; M J P. Welters [Pays-Bas] ; S H Van Der Burg [Pays-Bas] ; J R Kroep [Pays-Bas]A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
001546 (2013) Peter N. Morcos [États-Unis] ; Xiaoping Zhang ; Christine Mcintyre ; Beate Bittner ; Lucy Rowell ; Zubair HussainPharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20.
001756 (2012) M. Gallego-Galisteo [Espagne] ; A. Villa-Rubio ; E. Alegre-Del Rey ; E. Márquez-Fernández ; J J Ramos-BáezIndirect comparison of biological treatments in refractory rheumatoid arthritis.
001A99 (2009) Misato Hashizume [Japon] ; Masahiko MiharaInfluence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
001B40 (2008) Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoThe recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis.
001B54 (2008) M. Hashizume [Japon] ; N. Hayakawa ; M. MiharaIL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
001B83 (2007) Yoshiyuki Ohsugi [Japon]Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.
001C17 (2005) Yoshiyuki Ohsugi [Japon] ; Nobuyuki Tsuchimoto[Pharmacological and clinical profile of anti-human IL-6 receptor antibody (tocilizumab, ACTEMRA), a novel therapeutic drug for Castleman's disease].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Recombinant Proteins" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Recombinant Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Recombinant Proteins
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021